Los Altos, CA, United States of America

Harold Edgar VanWart

This inventor holds 1 USPTO granted patent. Top assignee: Syntex (u.s.a.) Inc.. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Harold Edgar VanWart: Innovator in Aggrecanase Research

Introduction

Harold Edgar VanWart is a notable inventor based in Los Altos, California. He has made significant contributions to the field of biochemistry, particularly in the study of aggrecanase and its implications in various diseases. His work has paved the way for advancements in therapeutic applications.

Latest Patents

VanWart holds a patent for "Human aggrecanase and nucleic acid compositions encoding the same." This patent encompasses human aggrecanase and related polypeptides, as well as nucleic acid compositions that have diverse applications. These include research, diagnostics, and therapeutic agent screening applications. The patent also outlines methods for inhibiting aggrecanase activity in hosts and treating disease conditions associated with aggrecanase activity, such as rheumatoid arthritis, osteoarthritis, infectious arthritis, gouty arthritis, psoriatic arthritis, spondylosis, sports injuries, joint trauma, pulmonary disease, and fibrosis.

Career Highlights

VanWart has had a distinguished career, working at Syntex (U.S.A.) Inc., where he has contributed to groundbreaking research in his field. His expertise in aggrecanase has positioned him as a key figure in biochemistry and therapeutic development.

Collaborations

Throughout his career, VanWart has collaborated with esteemed colleagues, including Paul Klonowski and Renu Anand Ileller. These collaborations have further enhanced the impact of his research and innovations.

Conclusion

Harold Edgar VanWart's contributions to the field of aggrecanase research have been invaluable. His patent and work at Syntex (U.S.A.) Inc. highlight his role as an innovator in biochemistry. His research continues to influence therapeutic strategies for various diseases associated with aggrecanase activity.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…